The immune system plays a crucial role in maintaining health; however, accumulating evidence indicates that this system can be the target for immunotoxic effects caused by a variety of chemicals including the environmental pollutants of polychlorinated biphenyls, chlorinated dibenzo-p-dioxins, pesticides, and heavy metals. Adverse chemical-induced immunomodulation, which is studied within the discipline of immunotoxicology, may be expressed either as immunosuppressionfimmunodepression or immunoenhancement. The former may be manifested either as decreased resistance to opportunistic viral, bacterial, fungal, and other infectious agents or increased susceptibility to cancer. Immunoenhancement on the other hand may either increase the risk of autoimmune reactions or result in allergic reactions. This paper attempts to integrate several aspects of the immune system that are relevant to the assessment of potentially immunotoxic chemicals. Environ Health Perspect 103(Suppl 9): 17-22 (1995) 
Introduction
This review provides a general overview of immunotoxicology. The immune system evolved to protect the host from potentially pathogenic agents including microorganisms (viruses and bacteria), parasites, and fungi; to eliminate neoplastic cells; and to reject nonself components (1) . Differentiated lymphoid organs first appear in the primitive forms of fish, with an increase in structural definition through amphibians and reptiles to birds and mammals. Consequently, several biomarkers of the immune response can be specific for all vertebrates (2) . From the toxicologic point of view, the immune system can be a target for toxic effects of chemicals, therapeutic drugs, or any other foreign substances called xenobiotics (3) . Chemically induced immunotoxic effects are investigated within the discipline of immunotoxicology (4) (5) (6) (7) (8) . According to the recommendations of the International Seminar on the Immunological System as a Target for Toxic Damage:
"a chemical substance should be considered immunotoxic when undesired events of the chemical are: (i) a direct and/or indirect action of the xenobiotic (and/or its biotransformation product) on the immune system; or (ii) an immunologically based host response to the compound and/or its metabolite(s), or host antigens are modified by the compound or its metabolite(s)" (9) .
The adverse immunotoxic effects of xenobiotics include organ damage of the immune system, such as necrosis; multiple histopathologic effects in the thymus, the bone marrow, and the lymph nodes; chemical-induced cellular pathology, including abnormal proliferation of stem cells in the bone marrow; altered maturation of immunocompetent cells and changes in Band T-cell subpopulations; functional alterations of immunocompetent cells generally classified as altered humoralmediated immunity (HMI), cell-mediated immunity (CMI), or nonspecific responses (NSR); two-directional interaction of the immune system with xenobiotic detoxification and biotransformation mechanisms generally observed as an impairment of chemical elimination in immunodeficient individuals; xenobiotic-related in vivo functional immunopathology, such as weakened host resistance to viral and bacterial infections and to parasitic infestations; and altered immune surveillance mechanisms leading to increased incidence of cancer (10, 11) . Thus, structural and functional alterations of the immune system may lead to immunodepression/immunosuppression, which may modify the host defense mechanisms against infection and cancer, and induction of abnormal immune responses resulting in allergy and autoimmunity (4) (5) (6) (7) (8) (12) (13) (14) .
Diversity of Immunotoxic Effects
A number of chemical-induced immunotoxic effects have been reported; these effects can be organ specific, cell specific, immune function specific, they can be secondary following toxic effects of other organs, or they can be nonspecific (4, 5, (13) (14) (15) (16) (17) (19) . However, host defense mechanisms against various infectious agents involve different components of the immune system. Therefore, interpretation of experimental data is complicated when only a limited number of infectivity assays are used. For example, CPS was shown to affect host resistance in several viral and bacterial infections, except for herpes virus-2 (HSV-2) and C. neoformans for which even increased resistance in CPS-exposed animals was reported (27) . Therefore, data from several different experimental bacterial and viral infectivity models and experimental tumor models are often needed to conclusively demonstrate potential chemically induced alterations in host defense mechanisms.
It is generally accepted that efficient modification of the host's antitumor responses through augmentation or restoration of existing effector mechanisms might be beneficial (28, 29 (47, 48) . Overall, a variety of structural changes in the immune system observed during subchronic and chronic toxicity studies can be useful indicators of a potential immunotoxic effect of chemicals and can be used as a base in designing further immunotoxicity studies.
Evaluation of Chemicalinduced Immunotoxicity
The structural and functional complexity of the immune system requires that multiple parameters be examined for a comprehensive evaluation of chemically induced immunomodulation to be made.
Current guidelines for toxicity testing of chemicals published by the Organization of Economic Cooperation for Development (OECD) include bioassays for acute, shortterm, and long-term toxicity, as well as tests for carcinogenicity, mutagenicity, teratogenicity, and reproductive and developmental toxicity (49 (50) . Currently, efforts are been made internationally to modify the OECD guidelines to include additional immunerelated tests that may predict the immunotoxic potential of chemicals (H Koeter, personal communication). Meanwhile, a number of proposed guidelines and detailed methodology have been published for the assessment of chemically induced immunotoxicity using the mouse and the rat as the animal models (4, (6) (7) (8) (51) (52) (53) (54) . Due to the complexity of the immune system, a two-tier approach has been suggested. Tier I is usually a screen for potentially immunotoxic chemicals and contains assays that evaluate immunopathology, HMI, CMI, and NSI. Tier II consists of specific confirmatory immune tests and in-depth mechanistic studies. Tier II of the proposed guidelines for immunotoxicity testing also provides a comprehensive assessment of host resistance to challenge with syngeneic tumors and bacterial, viral, or parasitic agents (6, 7) . The inclusion of infectivity assays into Tier II is important since a higher incidence of mortality due to infection was observed in exprimental animals, wildlife, and fish whose immune systems were compromised following exposure to chemicals as compared to the incidence in nonexposed animals (20, (55) (56) (57) . Also, early epidemiologic studies indicated that decreased antiviral resistance in children could be a consequence of immunosuppression due to massive spraying of forestry insecticides or chemical carriers in the insecticide formulations (21) . Generally then, a series of quantitative and functional immunologic assays are designed to test for adverse effects of chemicals on the immune system.
Progress in intra-and interlaboratory validation of immunotoxicologic methods regarding their potential for predicting immune effects of xenobiotics revealed that the plaque-forming cell (PFC) technique, combined with the assays for natural killer (NK) cell activity, the analysis of lymphocyte subpopulations, the mitogen-induced B-and T-cell proliferation, and the DTH response, had a high degree of concordance with the predicted immunotoxic properties of chemicals (6) . These (50) , and investigations regarding the function of the antigen presenting cells following exposure to the organochlorine pesticide dieldrin revealed that the observed effect on antibody production was due to a chemical-related effect on antigen presentation by the mononuclear phagocytic cell (23, 24 (4, 6, 49) , the increased use of other species in immunotoxicity studies has prompted the development and validation of a number of immune assays in species other than rodents. Several of these assays were shown to be good predictors of the immunotoxic potential of environmental chemicals and included assays for nonhuman primates (15, 25, 26, 58, 59) , dogs (60) (61) (62) (63) (64) , marine mammals (65) , and fish (2, 57, 65) . Several new end points of potential usefulness in the assessment of chemically induced immunotoxicity have been proposed in recent years (4, 6, 16, 17, 42 (71) . The popliteal lymph node (PLN) enlargment in mice and rats was proposed as a predictive test of autoimmunity-inducing drugs (31, 32) . While the mechanism of PLN enlargment by low-moleculer autoimmunity-inducing drugs is not well understood, results obtained with the graft-versus-host technique and quantification of activated CD4+ and CD8+ T-cell subsets by flow cytometry provided unequivocal evidence for chemical-induced dysregulation leading to autoimmune phenomena (14, 31, 72) .
Finally, development of in vitro models for immunotoxicity testing would be clearly advantageous, especially in studies involving human peripheral blood lymphocytes directly exposed to the chemical of interest (17) . This approach, however, is restricted by the limited number of available in vitro techniques and the frequently observed lack of correlation between in vivo and in vitro results and is limited only to highly immunosuppressive chemicals that do not require metabolic activation (17, 47, 48) . A good example of new approaches in the in vitro studies is the increasing appreciation of the relevance of programmed cell death (apoptosis) (73 
